APA

Veschi V., Liu Z., Voss T. C., Ozbun L., Gryder B., Yan C., Hu Y., Ma A., Jin J., Mazur S. J., Lam N., Souza B. K., Giannini G., Hager G. L., Arrowsmith C. H., Khan J., Appella E. & Thiele C. J. (20170613). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. : Cancer cell.

Chicago

Veschi Veronica, Liu Zhihui, Voss Ty C, Ozbun Laurent, Gryder Berkley, Yan Chunhua, Hu Ying, Ma Anqi, Jin Jian, Mazur Sharlyn J, Lam Norris, Souza Barbara K, Giannini Giuseppe, Hager Gordon L, Arrowsmith Cheryl H, Khan Javed, Appella Ettore and Thiele Carol J. 20170613. Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. : Cancer cell.

Harvard

Veschi V., Liu Z., Voss T. C., Ozbun L., Gryder B., Yan C., Hu Y., Ma A., Jin J., Mazur S. J., Lam N., Souza B. K., Giannini G., Hager G. L., Arrowsmith C. H., Khan J., Appella E. and Thiele C. J. (20170613). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. : Cancer cell.

MLA

Veschi Veronica, Liu Zhihui, Voss Ty C, Ozbun Laurent, Gryder Berkley, Yan Chunhua, Hu Ying, Ma Anqi, Jin Jian, Mazur Sharlyn J, Lam Norris, Souza Barbara K, Giannini Giuseppe, Hager Gordon L, Arrowsmith Cheryl H, Khan Javed, Appella Ettore and Thiele Carol J. Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. : Cancer cell. 20170613.